| Vol. 11.22 – 9 June, 2022 |
| |
|
|
| A novel 3D microfluidic tri-culture platform was proposed for recapitulating positive feedback from brain metastatic NSCLC astrocytes and brain-specific endothelial cells, two major players in the brain tumor microenvironment. [Advanced Science] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists performed differential DNA methylation analyses of 398,186 individual CpG sites in primary bronchial epithelial cells from 42 nonasthma controls and 88 asthma cases, including 56 without maternal asthma (MA) and 32 with MA. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Silencing of α1,6-fucosyltransferase, the enzyme for core-fucosylation and highly expressed in lung stem cells, resulted in alveolar structural changes in lung organoids, recapitulating COPD. [Cellular and Molecular Life Sciences] |
|
|
|
| The authors systematically identified a crucial lncRNA, p53-induced long non-coding RNA TP53 target 1 (TP53TG1), which was the dysregulated hub gene in the idiopathic pulmonary fibrosis (IPF) regulatory network and one of the top degree genes down-regulated in IPF-derived fibroblasts. [Cell Death & Disease] |
|
|
|
| Scientists demonstrated that fibroblast growth factor-9 signaling primed the conducting airway epithelium to rapidly induce a localized type I interferon and proinflammatory cytokine response during viral infection. [PLoS Pathogens] |
|
|
|
| The authors investigated the effects of electronic cigarette vapor on human distal airway epithelial responses to influenza A virus infection. They isolated primary small airway epithelial cells from donor lungs free of lung disease, and cultured them at air–liquid interface. [Archives of Toxicology] |
|
|
|
| Recent studies have revealed that STAT3 expressed in epithelial cells protects against pathogens and maintains homeostasis in the intestine. Scientists elucidated the roles of airway epithelial STAT3 in allergic airway inflammation. [Allergology International] |
| |
|
|
| The authors revealed that circVAPA, derived from exons 2-4 of the vesicle-associated membrane protein-associated protein A gene, exhibited higher expression levels in SCLC cell lines, clinical tissues, and serum from SCLC patients than the controls, and facilitated SCLC progression in vitro and in vivo. [Molecular Cancer] |
|
|
|
| The study of over 1000 lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) tumors demonstrated that computationally derived patterns of tumor-infiltrating lymphocytes (TILs) on H&E images were different between LUAD and LUSC. [npj Precision Oncology] |
|
|
|
| The functions and mechanisms of circASCC3 in NSCLC progression and anti-programmed cell death 1 resistance were uncovered in vitro and in vivo. [Cancer Letters] |
|
|
|
| Scientists investigated cancer stem cell frequency and recurrence-related genes expression as predictors of disease-free survival in lung cancer. [Stem Cells Translational Medicine] |
|
|
|
| Abnormal expression of p120 catenin is associated with the malignant phenotype in human lung cancer. Researchers investigated the dynamic changes in nuclear p120 catenin localization during cell cycle progression. [Cell Death & Disease] |
|
|
|
| Investigators evaluated the role of junctional adhesion molecule-like protein in lung adenocarcinoma. [Journal of Translational Medicine] |
|
|
|
|
| The authors discuss how organ-on-a-chip has contributed to the understanding of human lung structure-function relationships at the cell, tissue, and organ levels. [Physiology] |
|
|
|
| Exploring the brain–lung axis not only helps us to understand the development of the disease from different aspects, but also provides an important target for treatment strategies. [Cellular and Molecular Neurobiology] |
|
|
|
|
| CStone Pharmaceuticals and Pfizer, Inc. announced that the National Medical Products Administration (NMPA) of China has approved sugemalimab for the treatment of patients with unresectable stage III NSCLC. [CStone Pharmaceuticals] |
|
|
|
| Oryzon Genomics, S.A. announced that the US FDA has granted Orphan Drug Designation to the company’s clinical-stage LSD1 inhibitor iadademstat for the treatment of patients with SCLC. [Oryzon Genomics, S.A.] |
|
|
|
|
| October 3 – 5, 2022 Vancouver, British Columbia, Canada |
|
|
|
|
|
| Temple University – Philadelphia, Pennsylvania, United States |
|
|
|
| German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany |
|
|
|
| La Jolla Institute for Immunology – La Jolla, California, United States |
|
|
|
| Norwegian University of Science and Technology -Trondheim, Norway |
|
|
|
| H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States |
|
|
|
|